Test Price
2,800 AED✅ Home Collection Available
COG8 Gene Glycosylation Disorder Type 2H Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
- Diagnostic Precision: 99.9% analytical sensitivity through ISO 9001:2015 accredited NGS workflow.
- Premium Home Collection: VIP mobile phlebotomy with ISO‑certified cold‑chain transport – 8 AM to 11 PM, 7 days a week.
- Expert Clinical Guidance: Complimentary post‑test tele‑consultation to interpret your molecular report with a DHA‑licensed specialist.
- Insurance & Billing: Direct insurance verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
The COG8 Gene Glycosylation Disorder Type 2H Genetic Test screens the entire coding region and splice sites of the COG8 gene using Next‑Generation Sequencing (Illumina® platform) to confirm or exclude a diagnosis of CDG‑IIh. This test is essential for individuals with unexplained developmental delay, hypotonia, coagulopathy, or multi‑system involvement suggestive of a congenital disorder of glycosylation.
| Feature | Our COG8 NGS Test | Single‑Gene Sanger Sequencing |
|---|---|---|
| Technology | NGS (Next‑Generation Sequencing) – full gene coverage with CNV detection | Sanger sequencing – limited to a few exons, no CNV analysis |
| Turnaround Time | 3–4 Weeks | 6–8 Weeks |
| Clinical Sensitivity | >99% for point mutations & intragenic CNVs | ~85% (misses deep intronic & copy‑number changes) |
Physician Insight & Safety Protocols
"A COG8 NGS test provides a molecular window into a rare metabolic pathway. While a positive result can clarify years of diagnostic odyssey, it must be correlated with biochemical glycosylation studies and clinical phenotype. I emphasise that no single gene test replaces comprehensive paediatric and metabolic evaluation."
– Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory Precautions Before Testing
Critical Medication & Safety Notice
Do not discontinue any prescribed medication or supplementation before genetic testing without explicit instruction from your treating physician. Abrupt changes may destabilise metabolic compensation.
Exclusion Criteria & Emergency Red Flags
Contraindications for Test Collection
- Exclusion Criteria: Severe haemodynamic instability, acute encephalopathic crisis requiring intensive care, inability to provide informed consent (except by legal guardian).
- Emergency Red Flags: If the patient experiences seizures, loss of consciousness, severe bleeding, or respiratory distress, proceed to the nearest emergency department immediately – do not delay for test collection.
Patient FAQ & Clinical Guidance
1. What exactly does the COG8 NGS test detect, and how will it affect my child’s management?
The COG8 NGS identifies single‑nucleotide variants, small insertions/deletions, and copy‑number alterations across the entire COG8 gene, enabling definitive diagnosis of congenital disorder of glycosylation type IIh and guiding targeted metabolic management, enzyme replacement eligibility, and familial recurrence risk estimation.
2. Is a blood sample from a finger prick enough, and what is the collection process?
Yes, we accept one drop of blood on an FTA card, whole blood, or extracted DNA, collected by our DHA‑licensed phlebotomist during a scheduled home visit that follows strict cold‑chain protocols; the entire procedure is pain‑minimised and completed in under 15 minutes.
3. How long do results take and can I discuss them with a specialist?
Results are available within 3 to 4 weeks. Once received, you may schedule a complimentary tele‑consultation with a DHA‑licensed genetic counsellor to interpret the report in the context of your family history and clinical presentation.
UAE Regulatory & Data Privacy Adherence
- Federal Decree-Law No. 4 of 2016 on Medical Liability – patient consent and clinical safety protocols.
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) – full data privacy compliance.
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields – secure digital health data handling.
- ISO 9001:2015 Certified (INT/EGQ/2509DA/3139) – quality management systems.
Clinical & Logistical Metadata
| Test Name | COG8 Gene Glycosylation Disorder Type 2H Genetic Test (NGS) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Whole Blood (EDTA), FTA Card Spot, or Extracted DNA |
| Methodology Used | Next‑Generation Sequencing (NGS) on Illumina® Platform |
| ICD-10-CM Code | E77.8, Z14.8, Z82.79 |
| LOINC Code | 102286-1 |
| DHA Facility License & Laboratory Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians